Plains GP L.P. (PAGP)
NASDAQ: PAGP
· Real-Time Price · USD
18.97
-0.08 (-0.42%)
At close: Aug 15, 2025, 9:53 AM
Plains GP L.P. Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 47.8B | 50.14B | 50.12B | 50.38B | 49.71B | 48.33B | 48.67B | 48.97B | 51.23B | 55.99B | 57.34B | 57.34B | 53.78B | 47.35B | 42.04B | 35.05B | 30.11B | 23.4B |
Cost of Revenue | 33.59B | 35.77B | 36.26B | 36.63B | 47.51B | 45.86B | 45.93B | 46B | 47.94B | 52.71B | 54.14B | 53.84B | 50.78B | 44.69B | 39.25B | 32.89B | 27.91B | 21.12B |
Gross Profit | 14.24B | 14.38B | 14.04B | 13.93B | 2.37B | 2.64B | 2.75B | 2.97B | 3.29B | 3.28B | 3.2B | 3.5B | 3B | 2.66B | 2.8B | 2.16B | 2.2B | 2.28B |
Operating Income | 1.2B | 1.34B | 1.17B | 1.51B | 1.4B | 1.4B | 1.24B | 781M | 960M | 993M | 857M | 1.5B | 1.04B | 397M | 843M | 178M | 469M | 916M |
Interest Income | 18M | 22M | 22M | 19M | 22M | 24M | 19M | 16M | 6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 1.31B | 1.48B | 1.27B | 1.55B | 1.45B | 1.45B | 1.61B | 1.5B | 1.79B | 1.69B | 1.41B | 1.67B | 1.03B | 511M | 712M | 76M | 304M | 663M |
Net Income | 136M | 145M | 103M | 166M | 162M | 171M | 572M | 564M | 919M | 902M | 668M | 708M | 300M | 200M | 61M | -43M | -2M | 83M |
Selling & General & Admin | 379M | 390M | 386M | 379M | 373M | 365M | 355M | 350M | 340M | 333M | 329M | 334M | 319M | 313M | 298M | 281M | 275M | 275M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 12.59B | 12.84B | 12.49B | 12.07B | 526M | 288M | 645M | 1.3B | 1.35B | 1.33B | 1.32B | 671M | 354M | 354M | -52M | -11M | -7M | 10M |
Operating Expenses | 12.96B | 13.23B | 12.88B | 12.45B | 899M | 966M | 1.31B | 1.97B | 2.01B | 1.97B | 1.96B | 1.62B | 1.56B | 1.5B | 1.36B | 1.29B | 1.26B | 1.27B |
Interest Expense | 409M | 395M | 383M | 387M | 387M | 386M | 389M | 390M | 392M | 396M | 405M | 411M | 418M | 426M | 426M | 428M | 435M | 436M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 46.6B | 48.74B | 48.87B | 48.82B | 48.26B | 46.93B | 47.34B | 48.07B | 49.95B | 54.68B | 56.1B | 55.47B | 52.35B | 46.2B | 40.61B | 34.18B | 29.17B | 22.39B |
Income Tax Expense | 191M | 249M | 204M | 212M | 152M | 134M | 189M | 159M | 273M | 273M | 225M | 312M | 166M | 93M | 111M | -31M | 8M | 18M |
Shares Outstanding (Basic) | 198M | 198M | 197M | 197M | 197M | 197M | 195.5M | 196M | 195M | 194M | 194M | 194M | 194M | 194M | 194M | 194M | 194M | 194M |
Shares Outstanding (Diluted) | 198M | 198M | 197M | 197M | 197M | 197M | 195.5M | 196M | 195M | 194M | 194M | 194M | 194M | 194M | 194M | 194M | 194M | 194M |
EPS (Basic) | 0.68 | 0.73 | 0.52 | 0.85 | 0.83 | 0.88 | 2.95 | 2.91 | 4.74 | 4.65 | 3.45 | 3.65 | 1.55 | 1.03 | 0.31 | -0.22 | -0.01 | 0.44 |
EPS (Diluted) | 0.68 | 0.73 | 0.52 | 0.85 | 0.83 | 0.88 | 2.95 | 2.91 | 4.74 | 4.65 | 3.45 | 3.65 | 1.55 | 1.03 | 0.31 | -0.22 | -0.01 | 0.44 |
EBITDA | 2.73B | 2.9B | 2.68B | 2.97B | 2.88B | 2.88B | 3.05B | 2.92B | 3.19B | 3.08B | 2.78B | 3.02B | 2.33B | 1.77B | 1.92B | 1.22B | 1.44B | 1.76B |
EBIT | 1.72B | 1.87B | 1.66B | 1.93B | 1.84B | 1.83B | 2B | 1.89B | 2.18B | 2.09B | 1.81B | 2.08B | 1.45B | 936M | 1.14B | 504M | 739M | 1.1B |
Depreciation & Amortization | 1.01B | 1.03B | 1.03B | 1.04B | 1.04B | 1.05B | 1.05B | 1.03B | 1.01B | 994M | 968M | 937M | 877M | 831M | 778M | 715M | 696M | 665M |